Women in healthcare leadership and the impact of COVID-19 on startups? ?? GIANT Health-tech news
The "5000 Women" Campaign Special Ticket Offer
To encourage women to attend The GIANT Health Event 2020, we're offering a special event ticket (FULL price ticket ￡895) to women for only ￡39.
This enormous, great value offer is for the month of March only.
Help us to promote diversity and buy a ticket now.
= = = =
What will be the impact of COVID-19 on your business?
Hello
In this week's newsletter we continue with our women's history month theme. We also discuss and want to know:
- What are the biggest reasons for lack of gender equality and leadership in healthcare? Please take our twitter poll and let us know your thoughts!
- What will be the biggest impact on startups as a result of COVID-19?
As always we look forward to hearing from you.
Barry Shrier, Founder, GIANT Health
+44 7776 132 517
PS: We are always on the lookout for talent, we're recruiting for a number of positions, view our latest roles here
= = = =
Please click the image above to be taken to the poll on twitter.
= = = =
HEALTHTECH NEWS
Startups and Founders urged to prepare for virus-related disruption
There has been a significant number of articles, facts and infographics distributed regarding COVID-19 and coronavirus. In the UK the NHS has been keeping people up to date via a dedicated health page as well as the normal channels. However, one of the questions now being asked by many is: How will COVID-19 affect us as individuals, how we work and our future businesses?
It is thought that start-ups may be particularly vulnerable to the disruptions caused by the spread of coronavirus. This means that founders and senior leadership should take active steps, now, to prepare for the potential economic downturn. This was the advice given by venture-capital giant Sequoia Capital.
The key things they urged founders to investigate and future-proof included (read more):
1. Cash runways
2. Fundraising
3. Sales forecasts
4. Marketing
5. Headcount
6. Capital Spending
What measures are you taking to minimise and manage the impact that COVID-19 may have on your colleagues, staff and/or business? Let us know here.
= = = =
Announcing a new module at GIANT Health 2020
We are announcing a new module at GIANT Health 2020, looking at technology innovation regarding viruses and their threat to humanity. This will include:
- Genetic mapping
- Technology innovation in vaccine development
- Applications of AI and Machine learning in epidemics and pandemics.
We would like to invite interested parties to contact us to discuss partnership opportunities.
Please see here for more details.
= = = =
FUNDING NEWS
Cera Care raises $70m (UK)
- $70 million
- Equity and Debt round
- Led by KairosHQ, Yabeo and others
Cera Care, is a technology assisted home care provider led by Dr Ben Maruthappu MBE, co-founder and CEO. The company uses digital services and artificial intelligence to improve the care of the elderly. With 2,000 employees and 20 offices across the UK the company delivers 10,000 care visits a day. The launch of their new SmartCare technology and analytics platform, allows them to predict health deteriorations before they occur.
Currently Cera Care has 50 public sector contracts including the NHS.They also have contracts with Uber, Deliveroo and IBM. This round of funding brings their total funding to date to $90 million. They intend on using the funding to nationally roll-out the SmartCare technology and analytics platform. They also intend on acquiring other home healthcare businesses.
Inovio wins grant (USA)
- $9 million
- Led by Coalition for Epidemic Preparedness Innovations (CEPI)
Inovio Pharmaceuticals, is a biotechnology company based in Pennsylvania. That concentrates on discovery and development of synthetic DNA products for the treatment of cancer and infectious diseases. Currently, it is the only company to have a phase 2 vaccine for coronavirus that caused Middle East respiratory syndrome. They were also enlisted to help during the Ebola outbreak in 2014 and Zika outbreak in 2016. The company developed INO-4800 on 10th January in three hours.
Inovio's participation in this developing effort is based on their DNA medicine platforms suitability to rapidly develop vaccines. Alongside their proven track record to develop vaccine development with respect to emerging viruses with pandemic potential. Their INO-4700 for MERS-CoV is now ready to undergo trial in the Middle East where MERS viral outbreaks initially occurred. Read more.
= = = =
Our Community
Would like to meet (WLTM):
Are you a student, analyst, or researcher in academia and want to get into health technology communications? Or, are you carrying out exciting health technology research that you want the community to hear about? If so, we would love to hear from you.
Want to know more and collaborate? Send us a line here.
= = = =
Reasons to be cheerful, Part 3:
We found an interesting and heartwarming blog from the couple that were stuck on a ship affected by Coronovirus. This post is on their first day, finally, back at home.
= = = =
GIANT Health reaches thousands of members of the global HealthTech community. Get in touch to discuss partnership opportunities.
Barry Shrier, Founder, GIANT Health
+44 7776 132 517
PS: If you're recruiting, looking for a hospital trial partner, in fundraising mode, looking for a job...please get in touch and we'll be happy to support you in this newsletter.
GIANT would like to thank our sponsors for their support, you guys are great!
This email was sent to [email protected]
why did I get this? unsubscribe from this list update subscription preferences
GIANT Health Event · 1-6 Speedy Place · Cromer Street · London, London WC1H 8BS · United Kingdom